| 000 | 01863 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250513170354.0 | ||
| 264 | 0 | _c19990517 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0022-510X | ||
| 024 | 7 |
_a10.1016/s0022-510x(98)00299-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDurelli, L | |
| 245 | 0 | 0 |
_aAutoimmune events during interferon beta-1b treatment for multiple sclerosis. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cJan 1999 |
||
| 300 |
_a74-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xadverse effects |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xcomplications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aThyroid Function Tests |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aFerrero, B | |
| 700 | 1 | _aOggero, A | |
| 700 | 1 | _aVerdun, E | |
| 700 | 1 | _aBongioanni, M R | |
| 700 | 1 | _aGentile, E | |
| 700 | 1 | _aIsoardo, G L | |
| 700 | 1 | _aRicci, A | |
| 700 | 1 | _aRota, E | |
| 700 | 1 | _aBergamasco, B | |
| 700 | 1 | _aDurazzo, M | |
| 700 | 1 | _aSaracco, G | |
| 700 | 1 | _aBiava, M A | |
| 700 | 1 | _aBrossa, P C | |
| 700 | 1 | _aGiorda, L | |
| 700 | 1 | _aPagni, R | |
| 700 | 1 | _aAimo, G | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 162 _gno. 1 _gp. 74-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-510x(98)00299-8 _zAvailable from publisher's website |
| 999 |
_c10024425 _d10024425 |
||